Aortic Stenosis With COmplex PCI (ASCOP) Features Retrospective Registry on Contemporary Management and Outcomes
ASCOP
1 other identifier
observational
100
1 country
1
Brief Summary
To describe the prevalence and clinical features of patients with severe aortic stenosis undergoing TAVI and concomitant clinically indicated, complex and/or high-risk PCI
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2022
CompletedFirst Submitted
Initial submission to the registry
February 20, 2023
CompletedFirst Posted
Study publicly available on registry
March 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedMarch 21, 2024
March 1, 2024
10 months
February 20, 2023
March 20, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
POCE
all-cause deaths, strokes (any), myocardial infarction and major bleedings
1 year
Study Arms (1)
ASCoP (severe Aortic Stenosis with Complex PCI features)
Subjects with severe aortic stenosis undergoing transcatheter aortic valve intervention and with concomitant, complex coronary artery disease with a clinical indication for percutaneous coronary intervention
Interventions
TAVI and PCI to be administered as per physician's indication and choice, in one or more stages
Eligibility Criteria
Severe, symptomatic aortic stenosis with an indication to TAVI 2. Concomitant, stable CAD with an indication to complex PCI, as anticipated by angiography, defined as follows (one or more features)
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
ASST GOM Niguarda
Milan, 20162, Italy
Related Publications (1)
Montalto C, Munafo AR, Soriano F, Arslani K, Brunner S, Verhemel S, Cozzi O, Mangieri A, Buono A, Squillace M, Nava S, Diez Gil JL, Scotti A, Foroni M, Esposito G, Mandurino-Mirizzi A, Bauer D, Ornelas B, Codner P, Piayda K, Porto I, Marco F, Sievert H, Kornowski R, Tousek P, Fischetti D, Latib A, Sanchez JS, Maffeo D, Bedogni F, Reimers B, Regazzoli D, Mieghem NV, Sondergaard L, Saia F, Toggweiler S, Backer O, Oreglia JA. Outcomes of complex, high-risk percutaneous coronary intervention in patients with severe aortic stenosis: the ASCoP registry. EuroIntervention. 2025 Apr 21;21(8):e426-e436. doi: 10.4244/EIJ-D-24-00933.
PMID: 40259842DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 20, 2023
First Posted
March 2, 2023
Study Start
December 1, 2022
Primary Completion
October 1, 2023
Study Completion
December 31, 2023
Last Updated
March 21, 2024
Record last verified: 2024-03